Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Joseph E. Eid
Person

Joseph E. Eid

Tracked across 1 events · 6 articles · First seen May 12, 2026 · Last active May 12, 2026

Sentiment
10
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 10
Tech
Geron RYTELO LR-MDS Study Results
Geron Corporation announced that the first real-world evidence study of its drug RYTELO (imetelstat) in patients with lower-risk myelodysplastic syndromes (LR-MDS) will be presented at the European Hematology Association (EHA) 2026 Congress. The investigator-sponsored study,…
Impact: Joseph E. Eid, M.D., Executive Vice President, Research and Development and Chief Medical Officer of Geron Corporation, commented on the positive results of the real-world study.
May 12, 2026 · 6 articles
NEWSDESK
Track Joseph E. Eid live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.